In 2016, Ironwood Pharmaceuticals, Inc.’s partner, Astellas Pharma Inc., received marketing
approval from the Japanese Ministry of Health, Labor, and Welfare for Linzess (linaclotide), and
in 2017, Astellas Pharma Inc. launched Linzess (linaclotide) in Japan.
In 2012, NPS Pharmaceuticals, Inc. received approval from the U.S. Food and Drug
Administration (FDA) for its drug Gattex (Teduglutide (rDNA origin)). Gattex 0.05 mg/kg/d
injection is a new, recombinant analog of human glucagon-like peptide 2, a protein involved in
the rehabilitation of the intestinal lining. It is indicated for the treatment of adult patients with
short bowel syndrome (SBS) who are dependent on parenteral support. Sucg frequent approval
is expected to cather peptide-based gastrointestinal disorders therapeutics market growth in near
future.
Report includes chapters which deeply display the following deliverable about industry :
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Research Objective and
Assumption
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Dynamics, Regulations, and
Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and
Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST
Analysis
• Global Peptide-Based Gastrointestinal Disorders Therapeutics Market, By Regions
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Competition by Manufacturers
including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales
Area and Product Type.
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Manufacturers Profiles/Analysis
including Company Basic Information, Manufacturing Base and Its Competitors.
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Manufacturing Cost Analysis
including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Peptide-Based Gastrointestinal Disorders Therapeutics Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.